They include clinical factors such as tumor size, stage and histological type, histological grade, number and scale of regional lymph node involvement, hormone-receptor levels (ER, PR), HER-2/neu expression level and nuclear DNA ploidy. The gene discussed is ERBB2; the disease is neoplasm.